NCT00145886
Source recordAI-normalized
Effect of 12 Months Treatment With rhPTH on Calcium Balance, Bone Turnover, Bone Mineral Density, and Bone Micro-architecture in Patients With Fractures Associated With Low Bone Turnover and Sclerosing Bone Disorders
The purpose of this study is to determine how treatment with a new medication, recombinant human parathyroid hormone (rhPTH) affects calcium balance and bone strength.
AI analysis
Indication: Osteopetrosis
Modality: small molecule
Target: rhPTH
Sponsor: University of Chicago
Source URL: ClinicalTrials.gov
Source updated: Jan 12, 2016
Ingested: Jun 19, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: rhPTH
View original source fields
Condition raw: Osteopetrosis
Condition normalized: Osteopetrosis
Modality raw: small molecule
Modality normalized: small molecule
Target raw: rhPTH
Target normalized: rhPTH